Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of July 2022. The report serves to announce the results of the Company's annual general meeting of shareholders held on July 19, 2022.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance update rather than a financial results report.
Material Changes
There are no material financial changes reported in this filing. The primary event is the shareholder approval of all proposals presented at the annual meeting.
Guidance, Outlook, and Management Commentary
The filing confirms that shareholders approved all proposals by the requisite majority under Israeli law. Attendance at the meeting included 156,739,369 ordinary shares, representing approximately 82.7% of the issued and outstanding ordinary shares as of the record date. No specific guidance, risks, or unusual items are detailed in this text.
Key Facts for Investors to Verify
- All shareholder proposals were approved at the July 19, 2022, annual meeting.
- Shareholder participation was approximately 82.7% of outstanding shares.
- Details of the specific proposals are contained in the Proxy Statement filed on June 13, 2022 (Exhibit 99.1).
- This filing contains no financial performance data for the period.